Nutra Pharma announces updates with EuroAmerican IP & BioArmor, LLC, a Service-Disabled Veteran-Owned Small Business for Sales through GoVets.com
September 25, 2018 08:30 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, Fla., Sept. 25, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter...
Nutra Pharma Announces Agreement to Launch Comprehensive Internet Marketing Campaign
July 17, 2018 08:30 ET
|
Nutra Pharma Corp.
Nutra Pharma is announcing its agreement with an Internet marketing firm for their Over-the-Counter Pain Remedies: Nyloxin® and Pet Pain-Away™ CORAL SPRINGS, Fla., July 17, 2018 (GLOBE NEWSWIRE) --...
Nutra Pharma Announces Direct Mail Campaign for Pet Pain-Away™ Private Label Brand
July 03, 2018 08:30 ET
|
Nutra Pharma Corp.
Nutra Pharma is announcing the next phase of marketing their Over-the-Counter (OTC) pain reliever for dogs and cats, Pet Pain-Away™ through their direct response partner, DEG Productions CORAL...
Nutra Pharma Signs Definitive Letter of Intent for $4 Million Joint Venture Financing
June 28, 2018 08:30 ET
|
Nutra Pharma Corp.
Nutra Pharma is announcing the execution of a Letter of Intent for a $4 Million financing to fund a joint venture for the marketing and distribution of the Company’s Over-the-Counter products. CORAL...
Nutra Pharma Announces Direct Response Television Campaign for Pet Pain-Away™
June 06, 2018 08:30 ET
|
Nutra Pharma Corp.
Nutra Pharma is announcing the next phase of marketing their Over-the-Counter (OTC) pain reliever for dogs and cats, Pet Pain-Away™ through their direct response partner, DEG Productions. CORAL...
Nutra Pharma Partners with NxGen Brands for Nyloxin® Distribution
April 19, 2018 08:30 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, Fla., April 19, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter...
Nutra Pharma Files Provisional Patent for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
April 10, 2018 08:30 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, Fla., April 10, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter...
Nutra Pharma Announces Corporate Updates
March 08, 2018 08:30 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, Fla., March 08, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis (MS)...
Nutra Pharma Files Provisional Patent for Nerve Agent Counter Measures
February 21, 2018 08:30 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, Fla., Feb. 21, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter...
Nutra Pharma Announces Nyloxin® Distribution Agreement for Australia and New Zealand
February 01, 2018 08:30 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, Fla., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis (MS) and HIV and that...